Evidence map›Paper›PMID 41090944›Full record

ArticleMicrobiology spectrum2025

Montelukast treats

Wei Cao, Dongjun Xu, Huijie Yu, Xuning Shen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wei CaoEmergency Medicine Department, Affiliated Hospital of Jiaxing University, Jiaxing University, Jiaxing, Zhejiang, China.ORCID 0009-0008-1542-2659
Dongjun XuEmergency Medicine Department, Affiliated Hospital of Jiaxing University, Jiaxing University, Jiaxing, Zhejiang, China.
Huijie YuEmergency Medicine Department, Affiliated Hospital of Jiaxing University, Jiaxing University, Jiaxing, Zhejiang, China.
Xuning ShenEmergency Medicine Department, Affiliated Hospital of Jiaxing University, Jiaxing University, Jiaxing, Zhejiang, China.ORCID 0000-0001-8196-4589

Funding

Jiaxing Key Discipline of Medicine - Emergency Medicine 2023-ZC-004Jiaxing Key Discipline of Traditional Chinese Medicine Surgery of Traditional Chinese Medicine 2023-ZYYCX-002Jiaxing Provinces and Cities Jointly Cultivate Discipline --General Surgery (Minimally Invasive) 2023-PYXK-001Medical and Health Science and Technology Project of Zhejiang Province 2023RC099National Key Clinical Specialty onstruction project-Oncology 2023-GJZK-001
6 · The paper itself

Abstract

IMPORTANCE: Montelukast showed promise as a repurposed treatment for multidrug-resistant

Indexed as

AcetatesAnti-Bacterial AgentsAnti-Inflammatory AgentsPneumococcal InfectionsQuinolinesSepsisStreptococcus pneumoniaeAnimalsBiofilmsCyclopropanesDisease Models, AnimalFemaleHumansMiceMicrobial Sensitivity TestsSulfidesAcetatesAnti-Bacterial AgentsAnti-Inflammatory AgentsCyclopropanesmontelukastQuinolinesSulfidesantibacterialanti-inflammatorymontelukastsepsisS. pneumoniae

Identifiers

PMID41090944
PMCPMC12584749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.